BECTON,DICKINS. 16/26BECTON,DICKINS. 16/26BECTON,DICKINS. 16/26

BECTON,DICKINS. 16/26

No trades
See on Supercharts

BOXA analysis



Key facts


Issue date
Dec 9, 2016
Maturity date
Dec 15, 2026
Outstanding amount
‪500.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.90% (Fixed)
Yield to maturity
2.62%
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.